Dragon's Blood (Croton) (Croton lechleri)
What Is Dragon's Blood (Croton)?
Dragon's Blood (Croton) is listed botanically as Croton lechleri, a plant of the Euphorbiaceae family, native to the tropics of the Americas, Africa and Asia. The material in circulation is latex (tree sap) — an exudate pressed or drained from the living tissue. Most people search for it simply as Dragon's Blood (Croton); suppliers, pharmacopoeias and interaction databases list it as Croton lechleri, and matching the two is the first step in identifying what is actually in a product. Its character is described as resinous, slightly sweet, mildly astringent, which is often how the raw material is checked for quality.
Use of Dragon's Blood (Croton) predates its chemical analysis by a long way: earlier records describe it by season, preparation and the part gathered rather than by any constituent, and that practical knowledge is what later study was measured against. Beyond its practical use it carries cultural associations — sacred healing sap in Amazonian shamanic traditions and used for spiritual protection and energy sealing.
Today most searches for Dragon's Blood (Croton) come from people reading about wound healing, anti aging, antiviral and antibacterial, or checking how it sits alongside a medication they already take. The use most often documented in the literature is wound healing — forms protective film over wounds, followed by antiviral — crofelemer approved for HIV-associated diarrhea.
How Does Dragon's Blood (Croton) Work?
Dragon's Blood (Croton) works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in latex (tree sap) rather than by one marker molecule.
Before its chemistry was known, Dragon's Blood (Croton) was judged by what it did in the cup: how strongly it brewed, how it tasted, and how little or much was needed. Those notes are why particular preparations survived and others did not.
The research base is developing: there are human trials, though sample sizes and designs vary, and this profile cites 2 sources. Reported findings centre on crofelemer (SP-303) received FDA approval in 2012 for HIV-associated diarrhea. Where research exists, it examines wound healing — forms protective film over wounds, antiviral — crofelemer approved for HIV-associated diarrhea and anti-inflammatory and antioxidant proanthocyanidins. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into fixed oil and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
Dragon's Blood (Croton) is studied as a whole preparation because isolating one fraction tends to behave differently from the material it was taken out of — a recurring finding across the plant-chemistry literature.
Because these constituents are processed by the same pathways that handle many medicines, Dragon's Blood (Croton) is documented as interacting with antiretrovirals. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Dragon's Blood (Croton) can differ substantially; this is why reference entries specify latex (tree sap) and, where they exist, standardisation markers.